Skip to search boxSkip to navigationSkip to main content

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF CYSTIC ECHINOCOCCOSIS IN CHILDREN FROM AT A TERTIARY CENTER IN PERU

Original title: CARACTERÍSTICAS CLÍNICAS Y EPIDEMIOLÓGICAS DE EQUINOCOCOSIS QUÍSTICA EN NIÑOS DE UN CENTRO TERCIARIO EN PERÚ
  • Blanca Salazar-Mesones
    ,
  • Medalit Luna-Vílchez
    ,
  • Julio Maquera-Afaray
    ,
  • Christian Chiara-Chilet
    ,
  • Diana Portillo-álvarez
    ,
  • José Wagner López Revilla(corresponding author)
*Corresponding author for this work
  • Instituto Nacional de Salud del Niño San Borja
    ,
  • Universidad Privada de Tacna
    ,
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

Spanish

Pages from-to (Number of pages)

Pages 65-69 (5 pages)

Journal (Volume, Issue Number)

Revista Peruana de Medicina Experimental y Salud Publica (Volume 39, Issue 1)

Publication milestones

  • Published - 2022

Publication status

Published - 2022

ISSN

1726-4634

Publication IDs

  • Scopus: 85128432422

Abstract

Cystic echinococcosis (CE) in children is a public health problem. To describe the clinical and epidemio-logical profile of CE, we reviewed the records of 55 children admitted to our institution with a confirmed diagnosis of CE between 2017-2019, analyzing demographic data, clinical manifestations, and treatment. Male sex was 61,8% (34/55), median age was 9,25+2,79 years; 16,4% had previous CE diagnosis, and 50,9% had contact with dogs. The median time of illness was 2 months. 65,5% had hepatic involvement, 56,4% had pulmonary involvement, and 21,8% had both hepatic and pulmonary involvement. The most frequent symptoms were abdominal pain (80,6%) and cough (80,6%). Surgical treatment was performed in 87,5% of hepatic CE and 100% of pulmonary CE and hepatic and pulmonary CE. Albendazole was prescribed in 100% of hepatic cases, in 73,7% of pulmonary cases, and 75% of both affections. No mortality was reported.

Funding Details

Se agradece a la Unidad de Desarrollo de Investigación, Tecnologías y Docencia (UDITD) del INSN-SB por el soporte brindado para el desarrollo del presente trabajo de investigación.
FundersFunding numbers
UDITD
-
Unidad de Desarrollo de Investigación, Tecnologías y Docencia
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
3
Captures
36

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well